Careers  |  Sign In  |  Register  |   Twitter

Alzheimer’s Disease

A healthcare crisis

Joshua Grill, PhD, Director, Katherine and Benjamin Kagan Alzheimer’s Disease Treatment Development Program, UCLA, Alzheimer’s Disease, which is currently a worldwide healthcare crisis and it is expected to affect 15 million people worldwide by 2010.


Dean RA, Shaw LM.
Use of Cerebrospinal Fluid Biomarkers for Diagnosis of Incipient Alzheimer Disease in Patients with Mild Cognitive Impairment.
Clin Chem. 2009 Nov 19.

Mattsson N, Blennow K, Zetterberg H.
CSF biomarkers: pinpointing Alzheimer pathogenesis.
Ann N Y Acad Sci. 2009 Oct;1180:28-35.

Kester MI, van der Vlies AE, Blankenstein MA, Pijnenburg YA, van Elk EJ, Scheltens P, van der Flier WM.
CSF biomarkers predict rate of cognitive decline in Alzheimer disease.
Neurology. 2009 Oct 27;73(17):1353-8.